Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
RG-6631 by F. Hoffmann-La Roche for Autoimmune Disorders: Likelihood of Approval
RG-6631 is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Autoimmune Disorders. According to GlobalData,...
RG-6631 by F. Hoffmann-La Roche for Ulcerative Colitis: Likelihood of Approval
RG-6631 is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Ulcerative Colitis. According to GlobalData,...
RG-6631 by F. Hoffmann-La Roche for Crohn's Disease (Regional Enteritis): Likelihood of Approval
RG-6631 is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Crohn's Disease (Regional Enteritis). According...